Approval · Notice of Compliance 10984 · 2010
RAMIPRIL: Notice of Compliance 10984
Issued January 29, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10984
- Date
- January 29, 2010
- Company
- Cobalt Pharmaceuticals IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Additional product name
- Therapeutic class
- Angiotensin converting enzyme inhibitor
- Canadian reference product
- ALTACE (Hoechst Marion Roussel Canada Inc.)